Nutraceutical Composition Protecting Endothelial Cells via Nitric Oxide Stimulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Endothelial dysfunction, characterized by impaired nitric oxide production, leads to cardiovascular diseases, and existing treatments are inadequate in preventing or delaying its onset.
Innovation Solution
A nutraceutical composition, COMP-4, comprising ginger or its derivatives, L-arginine, L-citrulline, Muira puama, and Paullinia cupana, stimulates nitric oxide production through the iNOS and eNOS pathways, thereby protecting human arterial endothelial cells from dysfunction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments are used for endothelial dysfunction, then some symptomatic relief may be achieved, but the underlying nitric oxide production impairment remains unaddressed and disease progression continues
Solution Approach 1:
The patent applies preliminary action by administering the nutraceutical composition containing L-arginine, L-citrulline, ginger, Muira puama, and Paullinia cupana to stimulate nitric oxide production before endothelial dysfunction fully develops or progresses. This preventive approach addresses the root cause (impaired NO production) before it leads to irreversible cardiovascular damage, thereby improving treatment reliability while preventing harmful disease progression
Solution Approach 2:
The patent utilizes parameter changes by modifying the biochemical parameters of endothelial cells through nutraceutical supplementation. Specifically, it changes the concentration of nitric oxide, L-arginine, and L-citrulline in the system, thereby restoring normal endothelial function and preventing cardiovascular disease development without the harmful side effects of conventional pharmacological interventions
2Reliability
If nitric oxide production is stimulated through nutraceutical composition, then endothelial cell function is protected and improved, but the complexity of the treatment regimen increases
Solution Approach 1:
The patent applies merging by combining multiple nutraceutical components (L-arginine, L-citrulline, ginger, Muira puama, and Paullinia cupana) into a single integrated composition. This synergistic formulation addresses endothelial dysfunction through multiple mechanisms simultaneously (substrate provision, enzyme stimulation, antioxidant protection), thereby achieving reliable endothelial protection while presenting the treatment as a unified rather than complex multi-agent regimen
Solution Approach 2:
The patent utilizes universality by designing a nutraceutical composition that performs multiple functions: L-arginine and L-citrulline serve as substrates for nitric oxide synthesis, ginger provides antioxidant protection, and Muira puama and Paullinia cupana stimulate nitric oxide release. This multi-functional formulation achieves comprehensive endothelial protection through a single therapeutic intervention, reducing the perceived complexity for the patient
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
COMP-4 increases nitric oxide bioavailability and reduces pro-inflammatory cytokines like PAI-1, effectively mitigating endothelial dysfunction and potentially preventing cardiovascular diseases.
Implementation Method 1
stimulates nitric oxide production through the iNOS and eNOS pathways
Implementation Method 2
stimulates nitric oxide production through the iNOS and eNOS pathways
Data Source
AI summary
A method for protecting human arterial endothelial cells from endothelial cell dysfunction. The method includes administering a pharmaceutically effective amount of a composition over a sufficient period of time to stimulate NOS and protecting human arterial endothelial cells from endothelial cell dysfunction.